200,000+ products from a single source!
CAS No: 17834-04-7 Catalog No: AG0025YZ MDL No:
|Warfarin is an effective modifier of multiple UDP-glucuronosyltransferase enzymes: evaluation of its potential to alter the pharmacokinetics of zidovudine.||Journal of pharmaceutical sciences 20150101|
|Responsiveness to low-dose warfarin associated with genetic variants of VKORC1, CYP2C9, CYP2C19, and CYP4F2 in an Indonesian population.||European journal of clinical pharmacology 20130301|
|Analysis of R- and S-hydroxywarfarin glucuronidation catalyzed by human liver microsomes and recombinant UDP-glucuronosyltransferases.||The Journal of pharmacology and experimental therapeutics 20120101|
|Hydroxywarfarin metabolites potently inhibit CYP2C9 metabolism of S-warfarin.||Chemical research in toxicology 20100517|
|Prediction of human disposition toward S-3H-warfarin using chimeric mice with humanized liver.||Drug metabolism and pharmacokinetics 20090101|
|Identification of hydroxywarfarin binding site in human UDP glucuronosyltransferase 1a10: phenylalanine90 is crucial for the glucuronidation of 6- and 7-hydroxywarfarin but not 8-hydroxywarfarin.||Drug metabolism and disposition: the biological fate of chemicals 20081101|